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Introduction
Highly active antiretroviral therapy (HAART) has been
shown to restore immunity and reduce the burden of
Human Immunodeficiency Virus (HIV) in patients with
HIV infections. Co-infection with HIV and the Human
Papilloma Virus has been estimated to be as high as
51% in HIV positive women. Recently effective HAART
has been shown to reduce the prevalence of HPV and
intraepithelial lesions on Papanicolaou (pap) smear. It is
unclear if HIV viral suppression can reduce the inci-
dence of high grade cervical neoplasia .
Materials and methods
A retrospective cohort of 1090 women, in care from
2005 through 2008, had 389 referrals to colposcopy
clinic. 142 women mean age of 31.2 (range 17-54);
66.2% Non -Hispanic black,9.9% Non- Hispanic white,
and 23.9% Hispanic with HIV, median baseline CD4 283
(IQR 87.75-508) had a colposcopy and a second proce-
dure, either colposcopy or excisional biopsy after a base-
line abnormal Pap smear. Follow-up biopsies were
performed with a median of 11.9 months (IQR 4.4-22.5)
There were no significant baseline differences in clinical
or demographic parameters between patients who were
suppressed with VL.
Results
Of 125 cases in which HAART was started before the
first colpsocopy; 26 had a normal colposcopy and 48
had CIN1. From the normal and low grade group, 19
women developed high grade CIN (7, suppressed and
12, not suppressed.) Effective HAART reduced the risk
of CIN2-CIS on a second biopsy by 83.2% (AHR 0.168;
C.I. = 0 .057 -.498; p< 0.001) adjusted for age at
diagnosis, race, smoking and baseline CD4. Higher base-
line CD4 was associated with a reduced risk of high
grade neoplasia (AHR=0.996; C.I. 0.993-0.999; p
Conclusions
Reducing HIV viral load and preserving CD4 cells early
in the course of HIV and HPV co-infection decreases
the incidence of high grade cervical neoplasia.
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